152 related articles for article (PubMed ID: 23075239)
1. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.
Leung F; Diamandis EP; Kulasingam V
Biomark Med; 2012 Oct; 6(5):613-25. PubMed ID: 23075239
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
Leung F; Diamandis EP; Kulasingam V
Adv Clin Chem; 2014; 66():25-77. PubMed ID: 25344985
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
4. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
5. Searching for a system: the quest for ovarian cancer biomarkers.
Rodland KD; Maihle NJ
Cancer Biomark; 2010-2011; 8(4-5):223-30. PubMed ID: 22045355
[TBL] [Abstract][Full Text] [Related]
6. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
7. Application of proteomics in ovarian cancer: which sample should be used?
Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
[TBL] [Abstract][Full Text] [Related]
8. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer: biomarker proteomic diagnosis in progress.
Zhang Y; Guo B; Bi R
Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
[TBL] [Abstract][Full Text] [Related]
10. The progress of proteomic approaches in searching for cancer biomarkers.
Kočevar N; Hudler P; Komel R
N Biotechnol; 2013 Mar; 30(3):319-26. PubMed ID: 23165098
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
12. Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.
Husseinzadeh N
Gynecol Oncol; 2011 Jan; 120(1):152-7. PubMed ID: 20934205
[TBL] [Abstract][Full Text] [Related]
13. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
14. Current clinical use of biomarkers for epithelial ovarian cancer.
Moore RG; Maclaughlan S
Curr Opin Oncol; 2010 Sep; 22(5):492-7. PubMed ID: 20613519
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma.
Chung KH; Lee DH; Kim Y; Kim TH; Huh JH; Chung SG; Lee S; Lee C; Ko JJ; An HJ
J Proteome Res; 2010 Jan; 9(1):451-7. PubMed ID: 19902980
[TBL] [Abstract][Full Text] [Related]
16. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
[TBL] [Abstract][Full Text] [Related]
17. An overview of biomarkers for the ovarian cancer diagnosis.
Zhang B; Cai FF; Zhong XY
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
[TBL] [Abstract][Full Text] [Related]
18. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
19. The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers.
Carvalho VP; Grassi ML; Palma CS; Carrara HHA; Faça VM; Candido Dos Reis FJ; Poersch A
Transl Res; 2019 Apr; 206():71-90. PubMed ID: 30529050
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer biomarkers for molecular biosensors and translational medicine.
Suh KS; Park SW; Castro A; Patel H; Blake P; Liang M; Goy A
Expert Rev Mol Diagn; 2010 Nov; 10(8):1069-83. PubMed ID: 21080822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
